Oral targeted therapy for the treatment of non-small cell lung carcinoma

被引：5
作者：
Phillips, William J. [1 ]
Leighl, Natasha B. [2 ]
Blais, Normand [3 ]
Wheatley-Price, Paul [1 ,4 ]
机构：
[1] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[2] Univ Toronto, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada
[3] Univ Montreal, CHU Montreal, Dept Med, Montreal, PQ, Canada
[4] Ottawa Hosp Res Inst, Ottawa, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2024年 / 196卷 / 16期
关键词：
CANCER; CHEMOTHERAPY; PROGRESSION;
D O I：
10.1503/cmaj.231562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E558 / E561
页数：4
相关论文
共 15 条
[1]   Projected estimates of cancer in Canada in 2022 [J].
Brenner, Darren R. ;
Poirier, Abbey ;
Woods, Ryan R. ;
Ellison, Larry F. ;
Billette, Jean-Michel ;
Demers, Alain A. ;
Zhang, Shary Xinyu ;
Yao, Chunhe ;
Finley, Christian ;
Fitzgerald, Natalie ;
Saint-Jacques, Nathalie ;
Shack, Lorraine ;
Turner, Donna ;
Holmes, Elizabeth .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (17) :E601-E607
[2]   Oncogenic driver mutations in non-small cell lung cancer: Past, present and future [J].
Chevallier, Mathieu ;
Borgeaud, Maxime ;
Addeo, Alfredo ;
Friedlaender, Alex .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (04) :217-237
[3]   Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial [J].
Drilon, Alexander ;
Subbiah, Vivek ;
Gautschi, Oliver ;
Tomasini, Pascale ;
de Braud, Filippo ;
Solomon, Benjamin J. ;
Tan, Daniel Shao-Weng ;
Alonso, Guzman ;
Wolf, Juergen ;
Park, Keunchil ;
Goto, Koichi ;
Soldatenkova, Victoria ;
Szymczak, Sylwia ;
Barker, Scott S. ;
Puri, Tarun ;
Bence Lin, Aimee ;
Loong, Herbert ;
Besse, Benjamin .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :385-+
[4]   Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial [J].
Majem, Margarita ;
Goldman, Jonathan W. ;
John, Thomas ;
Grohe, Christian ;
Laktionov, Konstantin ;
Kim, Sang-We ;
Kato, Terufumi ;
Vu, Huu Vinh ;
Lu, Shun ;
Li, Shanqing ;
Lee, Kye Young ;
Akewanlop, Charuwan ;
Yu, Chong-Jen ;
de Marinis, Filippo ;
Bonanno, Laura ;
Domine, Manuel ;
Shepherd, Frances A. ;
Atagi, Shinji ;
Zeng, Lingmin ;
Kulkarni, Dakshayini ;
Medic, Nenad ;
Tsuboi, Masahiro ;
Herbst, Roy S. ;
Wu, Yi-Long .
CLINICAL CANCER RESEARCH, 2022, 28 (11) :2286-2296
[5]   Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study [J].
Mok, T. ;
Camidge, D. R. ;
Gadgeel, S. M. ;
Rosell, R. ;
Dziadziuszko, R. ;
Kim, D-W ;
Perol, M. ;
Ou, S-H, I ;
Ahn, J. S. ;
Shaw, A. T. ;
Bordogna, W. ;
Smoljanovic, V ;
Hilton, M. ;
Ruf, T. ;
Noe, J. ;
Peters, S. .
ANNALS OF ONCOLOGY, 2020, 31 (08) :1056-1064
[6]   Patient-Reported and End-of-Life Outcomes Among Adults With Lung Cancer Receiving Targeted Therapy in a Clinical Trial of Early Integrated Palliative Care: A Secondary Analysis [J].
Petrillo, Laura A. ;
El-Jawahri, Areej ;
Gallagher, Emily R. ;
Jackson, Vicki A. ;
Temel, Jennifer S. ;
Greer, Joseph A. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 62 (03) :E65-E74
[7]   Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC [J].
Ramalingam, S. S. ;
Vansteenkiste, J. ;
Planchard, D. ;
Cho, B. C. ;
Gray, J. E. ;
Ohe, Y. ;
Zhou, C. ;
Reungwetwattana, T. ;
Cheng, Y. ;
Chewaskulyong, B. ;
Shah, R. ;
Cobo, M. ;
Lee, K. H. ;
Cheema, P. ;
Tiseo, M. ;
John, T. ;
Lin, M-C ;
Imamura, F. ;
Kurata, T. ;
Todd, A. ;
Hodge, R. ;
Saggese, M. ;
Rukazenkov, Y. ;
Soria, J-C ;
Boyer, Michael ;
Lee, Chee ;
Hughes, Brett ;
O'Byrne, Kenneth ;
Briggs, Peter ;
Milward, Michael ;
John, Thomas ;
Demedts, Ingel ;
Vansteenkiste, Johan ;
Bustin, Frederique ;
Barrios, Carlos Henrique ;
Timcheva, Constanta ;
Butts, Charles ;
Goss, Glenwood ;
Juergens, Rosalyn ;
Leighl, Natasha ;
Cheng, Susanna ;
Burkes, Ronald ;
Zhou, Caicun ;
Zhang, Helong ;
Shu, Yongqian ;
Cheng, Ying ;
Zhou, Qing ;
Li, Wei ;
Feng, Guosheng ;
He, Yong .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :41-50
[8]   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].
Schiller, JH ;
Harrington, D ;
Belani, CP ;
Langer, C ;
Sandler, A ;
Krook, J ;
Zhu, JM ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :92-98
[9]   Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011 [J].
Shih, Ya-Chen Tina ;
Smieliauskas, Fabrice ;
Geynisman, Daniel M. ;
Kelly, Ronan J. ;
Smith, Thomas J. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) :2190-U232
[10]   Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study [J].
Skinner, Karen E. ;
Fernandes, Ancilla W. ;
Walker, Mark S. ;
Pavilack, Melissa ;
VanderWalde, Ari .
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) :192-200
12